Research strategy in industrial toxicology

Area of Science:

• Toxicology
• Pharmacokinetics
• Oncology

Background:

• Industrial toxicology often relies on observational data, necessitating further research for accurate human risk assessment.
• Inter-species extrapolation of toxic effects and understanding spontaneous tumor formation are key research areas.
• Spontaneous liver tumors in B6C3F1 mice show high activation of the H-RAS cellular oncogene.

Purpose of the Study:

• To develop and apply a physiologic pharmacokinetic model for methylene chloride (MeCl2) to enable accurate inter-species extrapolation of toxic effects.
• To investigate the role of cellular oncogenes in spontaneous tumor formation and their implications for interpreting chemical toxicity studies in animals.

Main Methods:

• Development of a physiologic pharmacokinetic model for methylene chloride (MeCl2) in multiple species, including humans.
• Analysis of spontaneous liver tumors in B6C3F1 mice to identify activated cellular oncogenes, specifically H-RAS.
• Comparison of oncogene activation frequencies between mouse tumors and human tumors.

Main Results:

• The MeCl2 pharmacokinetic model successfully predicts target tissue concentrations across species, allowing for dose-related toxicity assessments.
• Activated H-RAS oncogenes were found in 82% of spontaneous mouse liver tumors, significantly higher than the 10-20% incidence in human tumors.
• This high oncogene activation frequency suggests extreme sensitivity of this mouse strain to liver tumor induction.

Conclusions:

• Physiologic pharmacokinetic modeling provides a robust method for inter-species toxicity extrapolation, removing the need for arbitrary safety factors.
• Understanding oncogene activation in spontaneous animal tumors is critical for the accurate interpretation of chemical carcinogenicity studies.
• Further research is needed to elucidate the role of oncogenes in chemical carcinogenesis and to compare genotoxic and non-genotoxic carcinogen effects.